153 results on '"Lindnér, Per"'
Search Results
2. #1985 Tocilizumab in chronic active antibody-mediated rejection: a randomized controlled open-label multi-center trial (INTERCEPT study)
3. SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment—a randomized controlled multicenter trial
4. A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipients
5. Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
6. Survival and Quality of Life after Isolated Hepatic Perfusion with Melphalan as a Treatment for Uveal Melanoma Liver Metastases – Final Results from the Phase III Randomized Controlled Trial SCANDIUM
7. COVID-19 in solid organ transplant recipients: A national cohort study from Sweden
8. End‐ischemic hypothermic oxygenated machine perfusion does not improve renal outcome following liver transplantation from aged donors: A single‐center retrospective report.
9. Long and Short-Term Effects of Hypothermic Machine Perfusion vs. Cold Storage on Transplanted Kidneys from Expanded Criteria Donors—A Matched Comparison Study
10. Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
11. Molecular profiling of driver events in metastatic uveal melanoma
12. Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial
13. A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
14. Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion
15. Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden – a decade of follow‐up
16. Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
17. De första njurbytena mellan två skandinaviska länder är gjorda
18. Checkpoint Inhibition Causing Complete Remission of Metastatic Combined Hepatocellular-Cholangiocarcinoma after Hepatic Resection
19. Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis
20. Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
21. Isolated limb infusion for melanoma
22. Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours—an experimental study in rats
23. Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
24. Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma
25. Histamine pharmacokinetics in tumor and host tissues after bolus-dose administration in the rat
26. Presence of tumor-infiltrating CD8+ T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis.
27. Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis.
28. The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours
29. Gallbladder cancer – no improvement in survival over time in a Swedish population
30. Abstract 3683: Melphalan stimulates dendritic cell and CD8+ T cell expansion by inducing immunogenic cell death in melanoma cells
31. Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
32. Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion
33. Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 – active palliative treatment improved overall survival
34. Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
35. The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium
36. Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
37. MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma
38. An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation
39. Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma
40. Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma
41. Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 – active palliative treatment improved overall survival.
42. Regional cancer treatment - experimental studies
43. Treatment of primary liver cancer
44. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma
45. Validation of the internal reference technique for microdialysis measurements of interstitial histamine in the rat
46. Co-Localization of Fibrinolytic Activators and Inhibitors with Macrophages in Atherosclerotic Vessels
47. Influence of hepatic artery occlusion and desferrioxamine on liver-tumour growth
48. Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial
49. The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma
50. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.